SLC18A2 and Parkinson disease: Compared to the controls, lower levels of striatal VMAT2 binding were obtained in the caudate of LBD cases with a similar reduction (PD: −40.8%; PDD: −43.7%; DLB: −42.4%) of that shown in Fig. 4(a), statistical significance was reached vs. AD.